-
GSK plc American Depositary Shares (Each representing two) (GSK $39.99)
- $39.99 P/E (TTM): 23.86X Cap: $81.11B
- View GSK Profile
- View Questions on GSK
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Alibaba Group Holding Limited American Depositary Shares each representing eight (BABA $122.04)
- $122.04 P/E (TTM): 16.68X Cap: $286.78B
- View BABA Profile
- View Questions on BABA
-
Baidu Inc. (BIDU $89.56)
- $89.56 P/E (TTM): 10.03X Cap: $31.79B
- View BIDU Profile
- View Questions on BIDU
-
Novo Nordisk A/S (NVO $56.47)
- $56.47 P/E (TTM): 16.0X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
-
Tencent Holdings Ltd. ADR (TCEHY $75.94)
- $75.94 P/E (TTM): 29.41X Cap: $729.83B
- View TCEHY Profile
- View Questions on TCEHY
-
Novartis AG (NVS $127.05)
- $127.05 P/E (TTM): 21.3X Cap: $250.12B
- View NVS Profile
- View Questions on NVS
-
GSK plc American Depositary Shares (Each representing two) (GSK $39.99)
- $39.99 P/E (TTM): 23.86X Cap: $81.11B
- View GSK Profile
- View Questions on GSK
-
JD.com Inc. (JD $30.77)
- $30.77 P/E (TTM): 8.56X Cap: $46.22B
- View JD Profile
- View Questions on JD
-
AstraZeneca PLC (AZN $80.07)
- $80.07 P/E (TTM): 35.73X Cap: $249.66B
- View AZN Profile
- View Questions on AZN
-
ASML Holding N.V. (ASML $767.94)
- $767.94 P/E (TTM): 33.76X Cap: $300.15B
- View ASML Profile
- View Questions on ASML
-
SAP SE ADS (SAP $274.63)
- $274.63 P/E (TTM): 87.8X Cap: $331.52B
- View SAP Profile
- View Questions on SAP
-
PDD Holdings Inc. (PDD $121.01)
- $121.01 P/E (TTM): 12.13X Cap: $175.90B
- View PDD Profile
- View Questions on PDD
-
Lvmh Moet Hennessy Louis Vuitton SE ADR - Level I (LVMUY $116.67)
- $116.67 Cap: $285.15B
- View LVMUY Profile
- View Questions on LVMUY
Q: Good morning, I am looking for an alternative to big American tech. Hopefully in Europe or perhaps Asia. When large Canadian pension plans are moving away from US investments, I think this is worth exploring. Would appreciate your thoughts.
-
GSK plc American Depositary Shares (Each representing two) (GSK $39.99)
- $39.99 P/E (TTM): 23.86X Cap: $81.11B
- View GSK Profile
- View Questions on GSK
Q: Would you recommend to buy, hold, or sell GSK?
I ask on behalf of a relative I help with investing. GSK is currently 1.3% of their portfolio. I had already been thinking of recommending that they sell when the news on June 3 came out:
"Shares of GSK dropped more than 9% on Monday, after a Delaware judge allowed more than 70,000 lawsuits alleging its discontinued heartburn drug Zantac caused cancer, to go forward, in a blow for the British drugmaker."
They are at a 15% loss with their GSK holding (less if you consider dividends), but luckily it is a small part of the portfolio.
I am leaning toward a 'sell recommendation' but am open to counter arguments.
Thanks so much!
I ask on behalf of a relative I help with investing. GSK is currently 1.3% of their portfolio. I had already been thinking of recommending that they sell when the news on June 3 came out:
"Shares of GSK dropped more than 9% on Monday, after a Delaware judge allowed more than 70,000 lawsuits alleging its discontinued heartburn drug Zantac caused cancer, to go forward, in a blow for the British drugmaker."
They are at a 15% loss with their GSK holding (less if you consider dividends), but luckily it is a small part of the portfolio.
I am leaning toward a 'sell recommendation' but am open to counter arguments.
Thanks so much!
-
BluEnergies Ltd. (BLU)
- Cap: $35M
- View BLU Profile
- View Questions on BLU
-
GSK plc American Depositary Shares (Each representing two) (GSK $39.99)
- $39.99 P/E (TTM): 23.86X Cap: $81.11B
- View GSK Profile
- View Questions on GSK
Q: With the offer on the table and the share price having moved so close to the asking price would you sell now? Also, could you please outline the details of the offer and the pros and cons. Thank you. John
Insiders
Share Information
SEC Filings
News and Media